🇮🇹 Paxlovid (Copackaged) in Italy

AIFA authorised Paxlovid (Copackaged) on 28 January 2022

Marketing authorisation

AIFA — authorised 28 January 2022

  • Marketing authorisation holder: Pfizer Europe MA EEIG
  • Status: approved

Paxlovid (Copackaged) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in Italy

Frequently asked questions

Is Paxlovid (Copackaged) approved in Italy?

Yes. AIFA authorised it on 28 January 2022.

Who is the marketing authorisation holder for Paxlovid (Copackaged) in Italy?

Pfizer Europe MA EEIG holds the Italian marketing authorisation.